Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after administration of a rectal dosage vehicle

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 8, 1996, Pages 1059-1063

  Watanabe, Yoshiteru ^a   Kiriyama, Miyuki ^a   Ito, Ritsuko ^a   Kikuchi, Rie ^a   Mizufune, Yuko ^a   Nomura, Hideaki ^b   Miyazaki, Masanao ^b   Matsumoto, Mitsuo ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

granulocyte colony stimulating factor; hollow type suppository; leukopoietic effect; rabbit; serum G CSF concentration; cyclodexin

Indexed keywords

ACETIC ACID; ALPHA CYCLODEXTRIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOPOIESIS; MALE; NONHUMAN; RABBIT; RECTAL DRUG ADMINISTRATION; SUPPOSITORY;

EID: 0029780681     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.1059     Document Type: Article

References (21)

1. This paper is Part III of "Studies of Drug Delivery Systems for Granulocyte Colony-Stimulating Factor." Part II: Watanabe Y., Kikuchi R., Kiriyama M., Nakagawa K., Oe J., Nomura H., Maruyama K., Matsumoto M., Biol. Pharm. Bull., 18. 1084 (1995). And this paper constitutes Part XXI of a series entitled "Pharmaceutical Evaluation of Hollow-Type Suppositories." Part of this study was presented at the 7th Japanese-American Conference on Pharmacokinetics and Biopharmaceutics. Hiroshima, Japan, August 1994.
2. Souza L. M., Boone T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewski J., Lu H., Chen K. K., Barendt J., Platzer E., Moore M. A. S., Mertelsmann R., Weite K., Science, 232, 61 (1986).
3. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamasaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H., Ono M., Nature (London), 319, 415 (1986).
4. Watanabe Y., Matsumoto Y., Yamguchi M., Kikuchi R., Takayama K., Nomura H., Maruyama K., Matsumoto M., Biol. Pharm. Bull., 16, 93 (1993).
5. Watanabe Y., Matsumoto Y., Kikuchi R., Kiriyama M., Ito R., Matsumoto M., Nomura H., Maruyama K., Int. J. Pharmaceut., 110, 93 (1994).
6. Machida M., Sano K., Arakawa M., Hayashi M., Awazu S., Pharm. Res., 10, 1372 (1993).
7. Watanabe Y., Matsumoto Y., Kikuchi R., Kiriyama M., Nakagawa K., Nomura H., Maruyama K., Matsumoto M., J Drug Targeting, 3, 231 (1995).
8. Watanabe Y., Matsumoto M., Yakugaku Zasshi, 104, 479 (1984).
9. Watanabe Y., Matsumoto Y., Baba K., Matsumoto M., J. Pharmacobio-Dyn., 9, 526 (1986).
10. Watanabe Y., Matsumoto Y., Matsumoto M., Jpn. J. Hosp. Pharm., 20, 121 (1994).
11. Watanabe Y., Matsumoto Y., Hori H., Funato H., Matsumoto M., Chem. Pharm. Bull., 39, 3007 (1991).
12. Watanabe Y., Matsumoto Y., Seki M., Takase M., Matsumoto M., Chem. Pharm. Bull, 40, 3042 (1992).
13. Merkus F. W. H. M., Schipper N. G. M., Hermens W. A. J. J., Romeijn S. G., Verhoef J. C., J. Controlled Release, 24, 201 (1993).
14. Tanaka H., Tokiwa T., J. Pharmacol. Exp. Ther., 251, 724 (1990).
15. Ritschel W. A., "Handbook of Basic Pharmacokinetics," 2nd ed., Drug Intelligence Publication, Hamilton, 1980, pp. 274-283.
16. Petros W. P., Pharmacotherapy, 12 (2 Pt 2), 32S (1992).
17. Merkus F. W. H. M., Verhoef J. C., Romeijn S. G., Schipper N. G. M., Pharm. Res., 8, 588 (1991).
18. Watanabe Y., Matsumoto Y., Kawamoto K., Yazawa S., Matsumoto M., Chem. Pharm. Bull., 40, 3100 (1992).
19. Irie T., Wakamatsu K., Arima H., Aritomi H., Uekama K., Int. J. Pharmaceut., 84, 129 (1992).
20. Shao Z., Krishnamoorthy R., Mitra A. K., Pharm. Res., 9, 1157 (1992).
21. Matsumoto Y., Watanabe Y., Tojima T., Murakoshi R., Murakami C., Matsumoto M., Drug Design and Delivery, 4, 247 (1989).